Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms.

Annals of laboratory medicine - 1 Jul 2018

Yang Naery, Park Sholhui, Cho Min Sun, Lee Miae, Hong Ki Sook, Mun Yeung Chul, Seong Chu Myong, Huh Hee Jin, Huh Jungwon

Abstract excerpt

BACKGROUND: This study aimed to determine GATA1 expression levels to better characterize subgroups in BCR/ABL1-negative myeloproliferative neoplasms (MPNs). METHODS: This study enrolled 49 patients diagnosed as having BCR/ABL1-negative MPN on the basis of the 2016 World Health Organization classification : nine polycythemia vera (PV), 17 essential thrombocythemia (ET), 12 prefibrotic primary myelofibrosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Cytogenetic Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fusion Proteins, bcr-abl

Share to GATA1 Transcription Factor

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Primary Myelofibrosis

Share to Thrombocythemia, Essential

Source

Open in PubMed Open full text

Identifiers

PMID: 29611379
DOI: 10.3343/alm.2018.38.4.296
PMCID: PMC5895858

Genes

GATA1
ABL1
BCR
JAK2
CALR
MPL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms.PMID 29611379Read ↗

Immunophenotypic changes in NRBCs of Philadelphia chromosome-negative myeloproliferative neoplasms and its clinical significanceSemantic proximity Read ↗

Clinical significance of Gata‐1, Gata‐2, EKLF, and c‐MPL expression in acute myeloid leukemiaSemantic proximity Read ↗

The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients.Semantic proximity Read ↗

Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms.Semantic proximity Read ↗

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosisSemantic proximity Read ↗

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signaturesSemantic proximity Read ↗

Association of mast cells and bone marrow reticulin fibrosis in patients with bcr-abl negative chronic myeloproliferative neoplasms.Semantic proximity Read ↗

WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes.Semantic proximity Read ↗

miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.Semantic proximity Read ↗

Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasmsSemantic proximity Read ↗

GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromesSemantic proximity Read ↗

Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.